{"version":"1.0","type":"link","title":"Association of endocrine immune-related adverse events with progression-free survival in advanced non-small cell lung cancer treated with PD-1/PD-L1 inhibitors with or without anlotinib.","author_name":"Sun F 외","author_url":"https://prs-insight.online/author/Sun%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96147","thumbnail_width":1200,"thumbnail_height":630}